Media Summary: Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral treatment ... In this video, Prof. Norah Terrault, Prof. Thomas Berg and Prof. Raymond Chung discuss the highlights and new advances ... Dr. Anthony Martinez, Medical Director of Hepatology at the University at Buffalo and Erie County Medical Center, discusses the ...

Aasld Easl Hcv Special Conference Session 2 Viral Resistance Perspectives For Clinicians - Detailed Analysis & Overview

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral treatment ... In this video, Prof. Norah Terrault, Prof. Thomas Berg and Prof. Raymond Chung discuss the highlights and new advances ... Dr. Anthony Martinez, Medical Director of Hepatology at the University at Buffalo and Erie County Medical Center, discusses the ... The management of chronic hepatitis B is evolving, and staying current with the latest DDW TV covered this exciting and informative State-of-the-Art Lecture which presented the very latest information on Be part of the solution. Liver disease affects millions, yet remains underdiagnosed and undertreated. Through the Project ECHO ...

Alcohol related liver disease remains the most important cause of liver disease morbidity and mortality in Europe and North ... Title: Understanding and Managing Multi-Class SAN FRANCISCO, Nov. 4 -- New treatments for Dr. John Scott gives updates on hepatitis B management from the revised 2025

Photo Gallery

AASLD/EASL HCV Special Conference Session 2: Viral Resistance Perspectives for Clinicians
AASLD/EASL HCV Special Conference Session 1: Birth Cohort Screening for HCV
Debrief of EASL Special Conference on New Perspectives in HCV Infection
Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines
AASLD/EASL Special Conference Session 3: Therapeutic Options
The Updated 2025 AASLD Hepatitis B Guidelines
AASLD: Hepatitis C Update Session Coverage
AASLD/ILTS Transplant Course-Bench & Bedside @ The Liver Meeting ® 2015
Liver Health ECHO Program 2025 Session #2: MASLD and CoMorbidities
EASL Studio S9E3 Promo: Hepatitis C
Debrief from EASL-AASLD Conference: Alcohol related Liver Disease
Roger Paredes | Understanding and Managing Multi-Class Resistance
Sponsored
Sponsored
View Detailed Profile
AASLD/EASL HCV Special Conference Session 2: Viral Resistance Perspectives for Clinicians

AASLD/EASL HCV Special Conference Session 2: Viral Resistance Perspectives for Clinicians

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral treatment ...

AASLD/EASL HCV Special Conference Session 1: Birth Cohort Screening for HCV

AASLD/EASL HCV Special Conference Session 1: Birth Cohort Screening for HCV

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral treatment ...

Sponsored
Debrief of EASL Special Conference on New Perspectives in HCV Infection

Debrief of EASL Special Conference on New Perspectives in HCV Infection

In this video, Prof. Norah Terrault, Prof. Thomas Berg and Prof. Raymond Chung discuss the highlights and new advances ...

Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines

Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines

Dr. Anthony Martinez, Medical Director of Hepatology at the University at Buffalo and Erie County Medical Center, discusses the ...

AASLD/EASL Special Conference Session 3: Therapeutic Options

AASLD/EASL Special Conference Session 3: Therapeutic Options

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral treatment ...

Sponsored
The Updated 2025 AASLD Hepatitis B Guidelines

The Updated 2025 AASLD Hepatitis B Guidelines

The management of chronic hepatitis B is evolving, and staying current with the latest

AASLD: Hepatitis C Update Session Coverage

AASLD: Hepatitis C Update Session Coverage

DDW TV covered this exciting and informative State-of-the-Art Lecture which presented the very latest information on

AASLD/ILTS Transplant Course-Bench & Bedside @ The Liver Meeting ® 2015

AASLD/ILTS Transplant Course-Bench & Bedside @ The Liver Meeting ® 2015

AASLD

Liver Health ECHO Program 2025 Session #2: MASLD and CoMorbidities

Liver Health ECHO Program 2025 Session #2: MASLD and CoMorbidities

Be part of the solution. Liver disease affects millions, yet remains underdiagnosed and undertreated. Through the Project ECHO ...

EASL Studio S9E3 Promo: Hepatitis C

EASL Studio S9E3 Promo: Hepatitis C

Hepatitis C

Debrief from EASL-AASLD Conference: Alcohol related Liver Disease

Debrief from EASL-AASLD Conference: Alcohol related Liver Disease

Alcohol related liver disease remains the most important cause of liver disease morbidity and mortality in Europe and North ...

Roger Paredes | Understanding and Managing Multi-Class Resistance

Roger Paredes | Understanding and Managing Multi-Class Resistance

Title: Understanding and Managing Multi-Class

Aug 2024 LabCoP Extended ECHO Session: Improving Hepatitis Testing through Adoption of WHO Guidance

Aug 2024 LabCoP Extended ECHO Session: Improving Hepatitis Testing through Adoption of WHO Guidance

This LabCoP Extended ECHO

AASLD: Hepatitis C Treatments Highlight Meeting

AASLD: Hepatitis C Treatments Highlight Meeting

http://www.medpagetoday.com SAN FRANCISCO, Nov. 4 -- New treatments for

2025 AASLD Guidelines for Hepatitis B

2025 AASLD Guidelines for Hepatitis B

Dr. John Scott gives updates on hepatitis B management from the revised 2025

Session 4  Symposium on Viral Hepatitis

Session 4 Symposium on Viral Hepatitis

Day 3, Hall 1 | INASL 2025.

EASL Recommendations on Treatment of Hepatitis C 2016

EASL Recommendations on Treatment of Hepatitis C 2016

... if these patients have rats testing

Hepatitis C Antiviral Resistance Revealed by Mount Sinai Scientists

Hepatitis C Antiviral Resistance Revealed by Mount Sinai Scientists

Hepatitis C Antiviral Resistance

Interview with 2015 AASLD President at The Liver Meeting® 2014

Interview with 2015 AASLD President at The Liver Meeting® 2014

AASLD

EASL Guidelines on Viral Hepatitis Elimination - Mojca Matičič, MD, PhD

EASL Guidelines on Viral Hepatitis Elimination - Mojca Matičič, MD, PhD

Title: